{"id":785962,"date":"2023-09-25T16:04:12","date_gmt":"2023-09-25T20:04:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/"},"modified":"2023-09-25T16:04:12","modified_gmt":"2023-09-25T20:04:12","slug":"clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/","title":{"rendered":"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SALT LAKE CITY, Sept.  25, 2023  (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis, today announced that it will participate in the Cantor Fitzgerald Annual Global Healthcare Conference. Rob Etherington, Chief Executive Officer, and Morgan Brown, Chief Financial Officer, will be participating in the presentation and 1&#215;1 investor meetings.<\/p>\n<p align=\"left\">\n        <strong>Dates:<\/strong> September 26-28, 2023<br \/><strong>Locatio<\/strong>n<strong>:<\/strong> InterContinental Barclay Hotel, New York, NY<br \/><strong>Date and Time of Presentation:<\/strong> September 26, 2023, at 1:35 p.m. ET<br \/><strong>Format:<\/strong> Presentation and 1&#215;1 meetings<\/p>\n<p align=\"left\">A webcast of the presentations, if available, will be available on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=W-odWh794K_dUe7Jrhb1FrcVgyXHc66iKfM2uAAZ1o1zXvdiyqO90-j3TZoLfO3b-StKMy4j8EJvwTCYb_JhGhRWeSL8y0bmFJNIVpjCGjE=\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a>\u201d section of the Clene website or you can register at the following link to view the webcast:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=C9haS9HUI_LN5HEcpkm3WvgBeQrStV08cmNFtoY4rOKbw7DCOuCPEj8IAhLFGgnO75GuNNIIgeMmrgF7doB5hdNGbJp5vI_JMiuZ1YuNOvkeb_gaOkIT4loACwJ15d7ZpS3TDzZCL6MHRNxNWahn3yiUUfHQ4SYcHX8cd7HDEZQ=\" rel=\"nofollow noopener\" target=\"_blank\"><strong>https:\/\/wsw.com\/webcast\/cantor19\/clnn\/2087547<\/strong><\/a><\/p>\n<p align=\"left\">\n        <strong><br \/>\n          <u>About Clene<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis. CNM-Au8<sup>\u00ae<\/sup> is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&amp;D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=btIpnHO86SwaSJdHCBJvCp9tEwt7M5qKpxKOY89Ch9WG3kt7AZyPvIOAzliQMl2kX9mOrPmWI4MEks9OyFDEXQ==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aRn1xmth7OueI8_PKhjIz-VImK3CYuSvBNeOSKkXA4VLS2jCOfJfcdB4JRMvbOb0dG84hRUEWnNBwebB4T30bsNigy-YzqWo4T5UO5Tim1GPVJFdlAiJhB5-NSDXDlbF\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E_mHThlt1QS9Ysw39bp7aEjTDQefiJpOtMY3kbTyF9q7Nkpu7cAvk-sM4Myz-s9-jpzd_Fx6DIyp6huSOcqG6tDEDEmIWPtfaxUer7VHcnI=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Contacts:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;float:left;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:50%;width:50%;min-width:50%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong><br \/>\n              <u>Media Contact<\/u><br \/>\n            <\/strong><br \/>\n            <br \/>Ignacio Guerrero-Ros, Ph.D., or David Schull<br \/>Russo Partners, LLC<br \/><a href=\"mailto:Ignacio.guerrero-ros@russopartnersllc.com\" rel=\"nofollow noopener\" target=\"_blank\">Ignacio.guerrero-ros@russopartnersllc.com<\/a><br \/><a href=\"mailto:David.schull@russopartnersllc.com\" rel=\"nofollow noopener\" target=\"_blank\">David.schull@russopartnersllc.com<\/a><br \/>(858) 717-2310<\/td>\n<td style=\"max-width:50%;width:50%;min-width:50%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong><br \/>\n              <u>Investor Contact<\/u><br \/>\n            <\/strong><br \/>\n            <br \/>Kevin Gardner<br \/>LifeSci Advisors<br \/><a href=\"mailto:kgardner@lifesciadvisors.com\" rel=\"nofollow noopener\" target=\"_blank\">kgardner@lifesciadvisors.com<\/a><br \/>617-283-2856<\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjIwNzZlNWQtYWE4Yy00YzdlLWE1YmYtYjg4ZDkwYTMwMmMzLTEyNTc5OTk=\/tiny\/Clene-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SALT LAKE CITY, Sept. 25, 2023 (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis, today announced that it will participate in the Cantor Fitzgerald Annual Global Healthcare Conference. Rob Etherington, Chief Executive Officer, and Morgan Brown, Chief Financial Officer, will be participating in the presentation and 1&#215;1 investor meetings. Dates: September 26-28, 2023Location: InterContinental Barclay Hotel, New York, NYDate and Time of Presentation: September 26, 2023, at 1:35 p.m. ETFormat: Presentation and 1&#215;1 meetings A webcast of the presentations, if available, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-785962","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SALT LAKE CITY, Sept. 25, 2023 (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis, today announced that it will participate in the Cantor Fitzgerald Annual Global Healthcare Conference. Rob Etherington, Chief Executive Officer, and Morgan Brown, Chief Financial Officer, will be participating in the presentation and 1&#215;1 investor meetings. Dates: September 26-28, 2023Location: InterContinental Barclay Hotel, New York, NYDate and Time of Presentation: September 26, 2023, at 1:35 p.m. ETFormat: Presentation and 1&#215;1 meetings A webcast of the presentations, if available, &hellip; Continue reading &quot;Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-25T20:04:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference\",\"datePublished\":\"2023-09-25T20:04:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/\"},\"wordCount\":281,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/\",\"name\":\"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=\",\"datePublished\":\"2023-09-25T20:04:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference - Market Newsdesk","og_description":"SALT LAKE CITY, Sept. 25, 2023 (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis, today announced that it will participate in the Cantor Fitzgerald Annual Global Healthcare Conference. Rob Etherington, Chief Executive Officer, and Morgan Brown, Chief Financial Officer, will be participating in the presentation and 1&#215;1 investor meetings. Dates: September 26-28, 2023Location: InterContinental Barclay Hotel, New York, NYDate and Time of Presentation: September 26, 2023, at 1:35 p.m. ETFormat: Presentation and 1&#215;1 meetings A webcast of the presentations, if available, &hellip; Continue reading \"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-25T20:04:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference","datePublished":"2023-09-25T20:04:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/"},"wordCount":281,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/","name":"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=","datePublished":"2023-09-25T20:04:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODAyMyM1ODMxMTU5IzIyNDY0NDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-cantor-fitzgerald-annual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/785962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=785962"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/785962\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=785962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=785962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=785962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}